KALV logo

KalVista Pharmaceuticals (KALV) Total Assets

Annual Total Assets

$235.40 M
+$52.20 M+28.49%

30 April 2024

KALV Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$200.20 M
-$35.21 M-14.96%

31 July 2024

KALV Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KALV Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+28.5%+44.3%
3 y3 years-13.5%-17.9%
5 y5 years+99.3%+78.7%

KALV Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-13.5%+28.5%-17.9%+75.7%
5 y5 years-13.5%+154.4%-26.4%+202.4%
alltimeall time-13.5%+3443.1%-26.4%+2913.2%

KalVista Pharmaceuticals Total Assets History

DateAnnualQuarterly
July 2024
-
$200.20 M(-15.0%)
Apr 2024
$235.40 M(+28.5%)
$235.40 M(+106.6%)
Jan 2024
-
$113.97 M(-17.9%)
Oct 2023
-
$138.74 M(-13.5%)
July 2023
-
$160.33 M(-12.5%)
Apr 2023
$183.20 M(-10.1%)
$183.20 M(-10.0%)
Jan 2023
-
$203.47 M(+25.0%)
Oct 2022
-
$162.84 M(-10.7%)
July 2022
-
$182.32 M(-10.6%)
Apr 2022
-
$203.88 M(-9.4%)
Apr 2022
$203.88 M(-25.0%)
-
Jan 2022
-
$225.05 M(-7.7%)
Oct 2021
-
$243.81 M(-5.9%)
July 2021
-
$259.13 M(-4.7%)
Apr 2021
$272.01 M(+194.0%)
$272.01 M(+310.9%)
Jan 2021
-
$66.21 M(-12.2%)
Oct 2020
-
$75.45 M(-10.1%)
July 2020
-
$83.90 M(-9.3%)
Apr 2020
$92.53 M(-21.7%)
$92.53 M(-10.1%)
Jan 2020
-
$102.94 M(-8.1%)
Oct 2019
-
$112.06 M(-6.5%)
July 2019
-
$119.88 M(+1.5%)
DateAnnualQuarterly
Apr 2019
$118.13 M(+92.4%)
$118.13 M(-6.6%)
Jan 2019
-
$126.53 M(-4.6%)
Oct 2018
-
$132.56 M(+130.1%)
July 2018
-
$57.62 M(-6.1%)
Apr 2018
$61.39 M(+78.7%)
$61.39 M(-7.9%)
Jan 2018
-
$66.66 M(+91.9%)
Oct 2017
-
$34.74 M(+12.9%)
July 2017
-
$30.78 M(-10.4%)
Apr 2017
$34.34 M(+38.8%)
$34.34 M(-9.7%)
Jan 2017
-
$38.05 M(+6.1%)
Sept 2016
-
$35.86 M(-5.6%)
June 2016
-
$38.01 M(-23.5%)
Apr 2016
$24.75 M(-56.4%)
-
Mar 2016
-
$49.67 M(-12.5%)
Dec 2015
$56.79 M(+754.8%)
$56.79 M(-8.5%)
Sept 2015
-
$62.08 M(-8.2%)
June 2015
-
$67.60 M(+776.5%)
Mar 2015
-
$7.71 M(+16.1%)
Dec 2014
$6.64 M(-34.3%)
$6.64 M(-38.8%)
Sept 2014
-
$10.86 M(+7.5%)
Dec 2013
$10.11 M(+18.5%)
$10.11 M
Dec 2012
$8.53 M
-

FAQ

  • What is KalVista Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for KalVista Pharmaceuticals?
  • What is KalVista Pharmaceuticals annual total assets year-on-year change?
  • What is KalVista Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for KalVista Pharmaceuticals?
  • What is KalVista Pharmaceuticals quarterly total assets year-on-year change?

What is KalVista Pharmaceuticals annual total assets?

The current annual total assets of KALV is $235.40 M

What is the all time high annual total assets for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high annual total assets is $272.01 M

What is KalVista Pharmaceuticals annual total assets year-on-year change?

Over the past year, KALV annual total assets has changed by +$52.20 M (+28.49%)

What is KalVista Pharmaceuticals quarterly total assets?

The current quarterly total assets of KALV is $200.20 M

What is the all time high quarterly total assets for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high quarterly total assets is $272.01 M

What is KalVista Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, KALV quarterly total assets has changed by +$61.45 M (+44.29%)